SCHEMBL20181883

SCHEMBL20181883

CC(/C(=C/Nc1ccc(F)cc1F)N=N)n1cc(-c2cnc(C(F)(F)F)nc2)c2c(N)ncnc21

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.40
NTRK3 Q16288 1/20 0.40
NTRK2 Q16620 1/20 0.40
CFTR P13569 8/20 0.39
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
PRKDC P78527 1/20 0.38
NEK7 Q8TDX7 5/20 0.37
EIF2AK3 Q9NZJ5 1/20 0.35
AXL P30530 1/20 0.35
FLT3 P36888 2/20 0.35
RIPK1 Q13546 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182362 0.92 CFTR (0.40) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182294 0.90 CFTR (0.40) NTRK1NTRK3NTRK2CFTRPIK3CD
SCHEMBL20182298 0.86 NEK7 (0.38) NTRK1NTRK3NTRK2PIK3CDPIK3CA
SCHEMBL20182278 0.85 CFTR (0.37) NTRK1NTRK3NTRK2CFTRNEK7
SCHEMBL20182231 0.85 NTRK1 (0.44) NTRK1NTRK3NTRK2PIK3CDPIK3CA
SCHEMBL20181910 0.84 CFTR (0.38) NTRK1NTRK3NTRK2CFTRPIK3CD
SCHEMBL20182197 0.82 CFTR (0.43) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182281 0.81 FLT3 (0.39) CFTRNEK7EIF2AK3FLT3RIPK1
SCHEMBL20182288 0.81 EIF2AK3 (0.39) CFTRPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20182291 0.80 NTRK1 (0.38) NTRK1NTRK3NTRK2PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed